| Application no. and date | 14802642.0 (espacenet) (Federated) (European Patent Register), 20141121 | | Patent/reg. no. and date | DK/EP 3071220, 20191225 | | Publication date | 20160928 | | Priority no. and date | EP 13193953, 20131121, CA 2834000, 20131121, US 201314086696, 20131121, US 201414182776, 20140218 | | EP pub. no. and date |
EP 3071220 20160928 | | Effective date | | | Applicant/owner | Apeiron Biologics AG, Campus-Vienna-Biocenter 5
1030 Wien, AT | | Applicant ref. no. | P70874DK01 | | Inventor | LOIBNER, Hans, Heimgasse 23
A-1230 Vienna, AT,
MUTSCHLECHNER, Oliver, Reisenbauerring 8/2/21
A-2351 Wiener Neudorf, AT,
LADENSTEIN, Ruth, Roterdstrasse 7-9/1/2/5
A-1160 Vienna, AT,
KLIER, Isabel, Fuhrmannsgasse 8/21
A-1080 Vienna, AT | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) | | Title | PRÆPARATER TIL AT BEHANDLE EN GD2-POSITIV CANCER | | Int. application no. | EP2014075315 | | Int. publication no. | WO2015075194 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
